The No PFAS in Cosmetics Act prohibits the sale of cosmetics in the United States if they contain intentionally added perfluoroalkyl or polyfluoroalkyl substances. This ban specifically targets fluorinated chemicals that manufacturers add to products for a functional or technical purpose, as well as certain breakdown products of those chemicals. The regulation will take effect on January 1, 2027, applying to all cosmetic products and their packaging. Additionally, the bill repeals a previous provision from the Modernization of Cosmetics Regulation Act of 2022 to ensure consistency with this new restriction.
The FECA Modernization and Cost Containment Act of 2026 updates the Federal Employees' Compensation Act to lower costs and improve care for injured federal workers. It requires federal agencies to contract with managed care networks, which will direct employees to specific providers for medical services except in emergencies. These networks must follow standardized treatment protocols, limit fees to established schedules, and submit annual reports on cost savings and provider performance. The bill also mandates the creation of a review board to monitor compliance and authorizes the use of predictive analytics to detect fraud in claims.
This bill, known as the ABLE MATCH Act, aims to help individuals with disabilities save money by providing a federal tax credit that is automatically deposited into their ABLE savings accounts. The program targets low-income earners by offering a 100% match on up to $2,000 of annual contributions, provided their income falls below 200% of the federal poverty limit, with the credit amount gradually decreasing for higher incomes. To support wider adoption, the legislation also authorizes the Treasury to award $5 million annually in grants to states for promoting these accounts and includes a requirement for collecting demographic data on account holders. These changes are designed to increase financial security for people with disabilities by encouraging savings without jeopardizing their eligibility for other government benefits.
The MediKids Act expands Medicaid eligibility to cover children and young adults up to age 26, regardless of their immigration status, and establishes a system for automatic enrollment of newborns that allows parents to opt out if other qualifying health coverage is available. The bill ensures that states provide full federal funding for these expanded groups and extends specific pediatric health services, such as Early and Periodic Screening, Diagnostic, and Treatment (EPSDT), to individuals up to age 26. Additionally, the legislation modifies tax rules to prevent this new Medicaid coverage from counting as minimum essential coverage for the purpose of individual health insurance tax penalties.
The Health Over Wealth Act requires for-profit corporations that own or invest in health care providers like hospitals and nursing facilities to submit detailed annual reports to the federal government on financial data, debt levels, staffing, and political spending. This legislation also mandates that hospitals notify the government 90 days before closing or reducing essential services and requires them to submit mitigation plans to protect patient access and staff. Additionally, the bill creates a task force to study the impact of private equity ownership on health care quality and gives the Secretary of Health and Human Services authority to deny licenses or impose penalties on firms that fail to comply with these transparency and accountability rules.
This resolution expresses support for reproductive justice as the United States approaches its 250th anniversary. It defines reproductive justice as the right to have children, not have children, and raise them in safe communities, emphasizing that these rights should not depend on race, income, or location. The document calls for policies that ensure universal access to comprehensive healthcare, including abortion and contraception, while condemning the criminalization of pregnancy outcomes and forced sterilization. Additionally, it advocates for universal paid family leave, affordable childcare, and medically accurate sex education to support families. Ultimately, the resolution frames reproductive freedom as a fundamental human right and a cornerstone of democracy rather than a privilege.
The Veteran Suicide Spousal Career Services Act expands eligibility for the Disabled Veterans Outreach Program to include spouses of veterans, as well as spouses of service members who died in the line of duty or by suicide related to a service-connected disability. By amending existing federal law, the bill ensures these eligible persons can access the career counseling and support services previously reserved for veterans. This change directly affects the families of those who served, allowing them to utilize the program's resources without needing to meet the veteran status requirement themselves. The legislation focuses on broadening the definition of who qualifies for assistance rather than creating new types of services or funding.
The Fertility Cost Relief Act allows individuals to withdraw up to $20,000 from their retirement accounts to pay for fertility treatments without incurring the usual early withdrawal penalty. This provision directly affects people seeking assisted reproductive technologies, such as in vitro fertilization, egg or sperm preservation, and fertility medications, as well as their spouses or domestic partners. The bill defines eligible expenses broadly and sets a lifetime limit on penalty-free withdrawals, with the dollar amount adjusted for inflation after 2026. To use this benefit, the funds must be spent on qualifying treatments within one year of being withdrawn from an eligible retirement plan.
The Cancer Drug Parity Act of 2026 requires group health plans and insurance coverage to treat the cost-sharing for oral cancer medications no less favorably than that for intravenously administered cancer drugs. This rule applies to FDA-approved oral cancer treatments that a treating physician deems medically necessary and clinically appropriate, ensuring that deductibles, copayments, and coinsurance rates are not higher for oral options. The legislation also prohibits plans from making changes that would increase out-of-pocket costs or impose stricter limitations on oral cancer drugs compared to injected ones, while still allowing for standard utilization controls like prior authorization. Additionally, the bill mandates a Government Accountability Office study within two years to assess the impact of these changes on patient costs and access.
The Seizure Safe Schools Act of 2026 directs the Secretary of Education to create guidance for elementary and secondary schools on how to ensure safety for students with epilepsy or other seizure disorders. This guidance, developed in cooperation with the Department of Health and Human Services, must be issued within six months of the bill's enactment and will outline steps for schools to support students through their existing Section 504 plans or Individualized Education Programs. The act also allows the Secretary of Education to update this guidance as needed in the future.
